Relevant bibliographies by topics / Integrin-targeting

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Integrin-targeting'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Integrin-targeting.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Integrin-targeting"

1

Boettner, Benjamin. "Targeting fibrotic integrin." Science-Business eXchange 6, no. 46 (2013): 1308. http://dx.doi.org/10.1038/scibx.2013.1308.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Estevez, Brian, Bo Shen, and Xiaoping Du. "Targeting Integrin and Integrin Signaling in Treating Thrombosis." Arteriosclerosis, Thrombosis, and Vascular Biology 35, no. 1 (2015): 24–29. http://dx.doi.org/10.1161/atvbaha.114.303411.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Färber, Stefanie Felicitas, Alexander Wurzer, Florian Reichart та ін. "Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6". ACS Omega 3, № 2 (2018): 2428–36. http://dx.doi.org/10.1021/acsomega.8b00035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Egorova, Elena A., and Maxim P. Nikitin. "Delivery of Theranostic Nanoparticles to Various Cancers by Means of Integrin-Binding Peptides." International Journal of Molecular Sciences 23, no. 22 (2022): 13735. http://dx.doi.org/10.3390/ijms232213735.

Full text
Abstract:
Active targeting of tumors is believed to be the key to efficient cancer therapy and accurate, early-stage diagnostics. Active targeting implies minimized off-targeting and associated cytotoxicity towards healthy tissue. One way to acquire active targeting is to employ conjugates of therapeutic agents with ligands known to bind receptors overexpressed onto cancer cells. The integrin receptor family has been studied as a target for cancer treatment for almost fifty years. However, systematic knowledge on their effects on cancer cells, is yet lacking, especially when utilized as an active target
APA, Harvard, Vancouver, ISO, and other styles
5

Ye, Yunpeng, and Xiaoyuan Chen. "Integrin Targeting for Tumor Optical Imaging." Theranostics 1 (2011): 102–26. http://dx.doi.org/10.7150/thno/v01p0102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Burkhart, David J., Brian T. Kalet, Michael P. Coleman, Glen C. Post та Tad H. Koch. "Doxorubicin-formaldehyde conjugates targeting αvβ3 integrin". Molecular Cancer Therapeutics 3, № 12 (2004): 1593–604. http://dx.doi.org/10.1158/1535-7163.1593.3.12.

Full text
Abstract:
Abstract We have reported the synthesis and biological evaluation of a prodrug to a doxorubicin active metabolite. Under physiologic conditions, release of the active metabolite, a conjugate of doxorubicin with formaldehyde, occurs with a half-life of 1 hour. To direct this prodrug to tumor, we designed two conjugates of the prodrug, doxsaliform, with the αvβ3-targeting peptides, CDCRGDCFC (RGD-4C) and cyclic-(N-Me-VRGDf) (Cilengitide). We now report the synthesis of these doxsaliform-peptide conjugates and their evaluation using MDA-MB-435 cancer cells. A hydroxylamine ether tether was used t
APA, Harvard, Vancouver, ISO, and other styles
7

Cai, Weibo, Sanjiv Sam Gambhir та Xiaoyuan Chen. "Multimodality tumor imaging targeting integrin αvβ3". BioTechniques 39, № 6S (2005): S14—S25. http://dx.doi.org/10.2144/000112091.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

E. Hagemeyer, Christoph, and Karlheinz Peter. "Targeting the Platelet Integrin GPIIb/IIIa." Current Pharmaceutical Design 16, no. 37 (2010): 4119–33. http://dx.doi.org/10.2174/138161210794519255.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cheng, Tsai-Mu, Wong-Jin Chang, Hsiu-Yi Chu та ін. "Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy". Cells 10, № 7 (2021): 1684. http://dx.doi.org/10.3390/cells10071684.

Full text
Abstract:
Integrin αvβ3, a cell surface receptor, participates in signaling transduction pathways in cancer cell proliferation and metastasis. Several ligands bind to integrin αvβ3 to regulate proliferation and metastasis in cancer cells. Crosstalk between the integrin and other signal transduction pathways also plays an important role in modulating cancer proliferation. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) activates the downstream integrin FAK to stimulate biological activities including cancer proliferation and metastasis. Blockage of signals related to integrin αvβ3 was shown t
APA, Harvard, Vancouver, ISO, and other styles
10

Jiang, Yaqun, Yu Long, Hao Ji та ін. "Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin αvβ3 for Pancreatic Cancer Imaging". Pharmaceutics 14, № 9 (2022): 1791. http://dx.doi.org/10.3390/pharmaceutics14091791.

Full text
Abstract:
Nowadays, pancreatic cancer is still a formidable disease to diagnose. The CXC chemokine receptor 4 (CXCR4) and integrin αvβ3 play important roles in tumor development, progression, invasion, and metastasis, which are overexpressed in many types of human cancers. In this study, we developed a heterodimeric tracer 68Ga-yG5-RGD targeting both CXCR4 and integrin αvβ3, and evaluated its feasibility and utility in PET imaging of pancreatic cancer. The 68Ga-yG5-RGD could accumulate in CXCR4/integrin αvβ3 positive BxPC3 tumors in a high concentration and was much higher than that of 68Ga-yG5 (p <
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Integrin-targeting"

1

Pilkington-Miksa, Michael. "The synthesis of modified integrin-targeting peptides for incorporation into lipid/integrin-targeting peptide/DNA transfection complexes." Thesis, University College London (University of London), 2005. http://discovery.ucl.ac.uk/1445789/.

Full text
Abstract:
Integrin-targeting peptides have been shown to increase transfection efficiency when included in a number of different non-viral vectors. In the case of Lipofectin/DN A complexes (LD), transfection efficiency has been shown to increase on incorporation of an integrin- targeting peptide (Lipid/Integrin-targeting peptide/DNA complexes), as seen by a 100-fold increase in luciferase expression. Efforts to improve the Lipofectin component of Lipid/Integrin-targeting peptide/DNA complexes continue to be made and consequently ways of increasing transfection efficiency through modifications to the int
APA, Harvard, Vancouver, ISO, and other styles
2

DiCara, Danielle. "Targeting alpha v beta 6 integrin for cancer imaging." Thesis, Queen Mary, University of London, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.522319.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Forgey, Cady. "Prevention of Chronic Inflammation by Targeting Macrophage Integrin aDb2." Digital Commons @ East Tennessee State University, 2020. https://dc.etsu.edu/etd/3849.

Full text
Abstract:
Macrophage integrin aDb2 promotes macrophage retention and accumulation within inflamed tissue, a key event in development of chronic inflammation. Recently, the P5 peptide was identified as a specific inhibitor for integrin aDb2 interaction with 2-(ω-carboxyethyl) pyrole (CEP), a ligand at inflammatory sites. This thesis aims to identify integrin aD I-domain amino acids involved in binding P5 peptide and likewise to CEP. We propose that non-conserved, basic amino acids of the integrin aDb2 I-domain are responsible for binding to P5 peptide and likewise to CEP. Eight amino acids were analyzed
APA, Harvard, Vancouver, ISO, and other styles
4

Waterhouse, Jodie Elizabeth. "Synthesis and application of integrin targeting lipopeptides in gene therapy." Thesis, Imperial College London, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405829.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Emmons, Michael Foster. "Targeting α4 Integrin Containing Complexes in Multiple Myeloma Using Peptidomimetics". Scholar Commons, 2012. http://scholarcommons.usf.edu/etd/4314.

Full text
Abstract:
In our previous work we demonstrated that the integrin antagonist, HYD1, induced necrotic cell death in myeloma cell lines in vitro and in vivo as a single agent. In order to further delineate biomarkers of response to HYD1 we developed an isogenic drug resistant variant named H929-60. We show that the acquisition of resistance towards HYD1 correlates with reduced expression of the cleaved α4 integrin subunit and beta 1 integrin. Moreover, we demonstrate that HYD1 interacts with α4 integrin in myeloma cells. Consistent with reduced VLA-4 expression, the resistant variant showed ablated funct
APA, Harvard, Vancouver, ISO, and other styles
6

Brunton, Fiona. "Targeting the osteoclast alpha v beta 3 integrin by phage display." Thesis, Queen Mary, University of London, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.511761.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

PINA, ARIANNA. "SYNTHESIS OF NEW RGD PEPTIDOMIMETIC-DRUG CONJUGATES TARGETING ΑVΒ3 INTEGRIN." Doctoral thesis, Università degli Studi di Milano, 2019. http://hdl.handle.net/2434/606167.

Full text
Abstract:
Abstract Nowadays, systemic administration of cytotoxic agents is one of the main keystones of modern anticancer chemotherapy. However, many drugs do not selectively localize into solid tumors, as they normally accumulate also in healthy organs (e.g. liver and kidney). As a result, severe side effects are caused by the suboptimal biodistribution profile, in combination with the non-specific mode of action of cytotoxic agents, preventing the drug administration at therapeutic doses. The targeted delivery of anticancer agents into solid tumors is emerging as encouraging approach to overcome the
APA, Harvard, Vancouver, ISO, and other styles
8

Harbottle, Richard Paul. "Development of a non-viral gene delivery system based on integrin targeting peptides." Thesis, Imperial College London, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326256.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

CORSO, A. DAL. "TUMOR TARGETING VIA INTEGRIN LIGANDS: SYNTHESIS AND BIOLOGICAL EVALUATION OF RGD PEPTIDOMIMETIC-DRUG CONJUGATES." Doctoral thesis, Università degli Studi di Milano, 2015. http://hdl.handle.net/2434/331100.

Full text
Abstract:
Peptides and peptidomimetics bearing the Arg-Gly-Asp peptide sequence have been demonstrated to bind with high affinity to αvβ3 Integrin, a heterodimeric transmembrane receptor overexpressed in several tumor cells. For these reasons, integrin ligands have been coupled to a variety of anticancer drugs, aiming at the selective delivery of the payload at the tumor site. This PhD work describes the conjugation of the peptidomimetic αvβ3 Integrin ligand cyclo[DKP-RGD] to different anticancer drugs (i.e. paclitaxel, daunorubicin and camptothecin) through peptide and disulfide linkers. The resulting
APA, Harvard, Vancouver, ISO, and other styles
10

LOPEZ, RIVAS PAULA. "SYNTHESIS OF INTEGRIN-TARGETING PRO-DRUGS FOR THE SELECTIVE RELEASE OF ANTI-TUMOR AGENTS." Doctoral thesis, Università degli Studi di Milano, 2018. http://hdl.handle.net/2434/584099.

Full text
Abstract:
In this PhD work, a variety of new SMDCs were designed and synthesized featuring different types of linkers and cytotoxic payloads. All of them were characterized and conjugated to peptidomimetic ligands bearing the RGD sequence (namely, the cyclo[DKP-RGD] and cyclo[RDGfK] compounds) aimed at targeting αVβ3 integrin receptor, which is overexpressed in many human cancers. Firstly, six new conjugates containing peptide linkers prone to cleavage in intracellular vesicles (such as the lysosomes) were synthesized and evaluated in vitro. The loss of potency generally displayed by these SMDCs in ant
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Integrin-targeting"

1

Patsenker, Eleonora, ed. Integrin Targeting Systems for Tumor Diagnosis and Therapy. Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7445-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Integrin Targeting Systems for Tumor Diagnosis and Therapy. Humana, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Patsenker, Eleonora. Integrin Targeting Systems for Tumor Diagnosis and Therapy. Springer New York, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Integrin-targeting"

1

Kampouri, Eleftheria E., Jonathan Tschopp, and Oriol Manuel. "α4-Integrin (and Other Leukocyte Integrin)-Targeting Agents." In Infectious Complications in Biologic and Targeted Therapies. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-11363-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Saraf, Poonam, Xiaoling Li, and Bhaskara Jasti. "Integrin Targeting Using RGD-Based Peptide Amphiphiles." In Methods in Pharmacology and Toxicology. Springer New York, 2015. http://dx.doi.org/10.1007/7653_2015_61.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mashreghi, Mohammad, and Mahmoud Reza Jaafari. "Active Targeting for Tumor Microenvironment: Integrin Binding Peptides." In Functional Lipid Nanosystems in Cancer. Jenny Stanford Publishing, 2021. http://dx.doi.org/10.1201/9781003056997-16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brandau, O., and R. Fässler. "Analysis of Integrin Function by Gene Targeting in Mice." In Transgenic Models in Pharmacology. Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-642-18934-0_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Majumder, Poulami, and Arabinda Chaudhuri. "Integrin-Mediated Targeting of Liposomally Bound siRNAs to Tumor Vasculatures." In Methods in Pharmacology and Toxicology. Springer New York, 2015. http://dx.doi.org/10.1007/7653_2015_54.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Neburkova, Jitka, Miroslav Hajek, Ivan Rehor, et al. "Targeting Glioma Cancer Cells with Fluorescent Nanodiamonds via Integrin Receptors." In Methods in Pharmacology and Toxicology. Springer New York, 2017. http://dx.doi.org/10.1007/7653_2017_68.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wang, Fei, Gang Wei, and Weiyue Lu. "Preparation and Evaluation of Integrin Receptor-Mediated Targeting Drug Liposomes." In Liposome-Based Drug Delivery Systems. Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-49231-4_15-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wang, Fei, Gang Wei, and Weiyue Lu. "Preparation and Evaluation of Integrin Receptor-Mediated Targeting Drug Liposomes." In Biomaterial Engineering. Springer Berlin Heidelberg, 2021. http://dx.doi.org/10.1007/978-3-662-49320-5_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Vehlow, Anne, Katja Storch, Daniela Matzke, and Nils Cordes. "Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology." In Molecular Radio-Oncology. Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-49651-0_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Park, Steven I., Renil Manat, Brian Vikstrom, Nail Amro, and Kit S. Lam. "Identification of Peptide Ligands for α4β1 Integrin Receptor as Potential Targeting Agents for Non-Hodgkin’s Lymphoma." In Peptides: The Wave of the Future. Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-010-0464-0_80.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Integrin-targeting"

1

Biswas, Sanchita, Xuhua Wang, Alma R. Morales, and Kevin D. Belfield. "Fluorescence Bioimaging with Integrin-targeting Block Copolymer Probes." In Biomedical Optics. OSA, 2010. http://dx.doi.org/10.1364/biomed.2010.bsud82.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bloch, Sharon, Kexian Liang, Richard B. Dorshow, Yunpeng Ye, and Samuel I. Achilefu. "Targeting the expression of integrin receptors in tumors." In Biomedical Optics 2004, edited by Alexander P. Savitsky, Lubov Y. Brovko, Darryl J. Bornhop, Ramesh Raghavachari, and Samuel I. Achilefu. SPIE, 2004. http://dx.doi.org/10.1117/12.533160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Murray, Elizabeth R., Nicholas F. Brown, Philip Howard та ін. "Abstract 958: Effective targeting of pancreatic ductal adenocarcinoma metastases with an integrin αvβ6-targeting peptide-drug conjugate". У Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-958.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vallath, Sabari, Emaunela Gadaletta, Claude Chelala та ін. "Abstract B42: Toward targeting integrin αvβ6 for the therapy of pancreatic cancer." У Abstracts: AACR Special Conference on Pancreatic Cancer: Progress and Challenges; June 18-21, 2012; Lake Tahoe, NV. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.panca2012-b42.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Moore, Kate M., Gareth J. Thomas, Stephen W. Duffy та ін. "Abstract B046: Therapeutic targeting of integrin αvβ6 in high-risk breast cancer". У Abstracts: AACR Special Conference on Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications - October 3-6, 2013; San Diego, CA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1557-3125.advbc-b046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Li, Zhang, Zhang Chun Li, Yan Ping та ін. "Design, activity determination and99mTc labeling of cyclic RGD dimer for targeting integrin αVβ3". У 2011 International Conference on Human Health and Biomedical Engineering (HHBE). IEEE, 2011. http://dx.doi.org/10.1109/hhbe.2011.6027894.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Karmakar, Partha, Kostiantyn Ziabrev, Samuel Achilefu, Dorota Grabowska, Gail Sudlow та Nibedita Sanyal. "Effect of linkers on the αvβ3 integrin targeting efficiency of cyclic RGD-conjugates." У Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications X, редактори Samuel Achilefu та Ramesh Raghavachari. SPIE, 2018. http://dx.doi.org/10.1117/12.2301223.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chu, Po-Chen, Ming-Chen Yang, Samuel K. Kulp, and Ching-Shih Chen. "Abstract 4455: Targeting a novel kras-integrin-linked kinase regulatory circuitry in pancreatic cancer." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-4455.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wettersten, Hiromi I., Toshiyuki Minami, Megan M. Kaneda та ін. "Abstract 3966: Targeting integrin αvβ3-expressing cancer stem cells to manipulate tumor-associated macrophages". У Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-3966.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bourn, Matthew, Safoura Mohajerani, Georgia Mavria та ін. "Targeting Tumour Vasculature using Integrin αvβ3 - Observation of Liposome Accumulation in Microfluidic Vasculature Networks". У Emerging Investigators in Microfluidics Conference. Fundació Scito, 2021. http://dx.doi.org/10.29363/nanoge.eimc.2021.024.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Integrin-targeting"

1

Andrews, Philip. Targeting Alpha5 Beta1 Integrin to Prevent Metastatic Breast Cancer Cell Invasion: PhScN Target Site Definition and Plasma Stability. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada612844.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Livant, Donna L. Targeting Alpha5 Beta1 Integrin to Prevent Metastatic Breast Cancer Cell Invasion: PhScN Target Site Definition and Plasma Stability. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada592840.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Andrews, Phillip C. Targeting Alpha5 Beta1 Integrin to Prevent Metastatic Breast Cancer Cell Invasion: PhScN Target Site Definition and Plasma Stability. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada594182.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Integrin-targeting' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography